GI
KURA icon

GAMMA Investing’s Kura Oncology KURA Stock Holding History

GAMMA Investing’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$16.5K Buy
1,541
+214
+16% +$2.39K ﹤0.01% 3059
2026
Q2 		$14.6K Buy
1,327
+540
+69% +$5.09K ﹤0.01% 3017
2026
Q1 		$6.4K Buy
787
+330
+72% +$2.83K ﹤0.01% 3270
2025
Q4 		$4.75K Buy
457
+340
+291% +$3.57K ﹤0.01% 3299
2025
Q3 		$1.03K Sell
117
-60
-34% -$428 ﹤0.01% 3608
2025
Q2 		$1.02K Sell
177
-204
-54% -$1.25K ﹤0.01% 3534
2025
Q1 		$2.52K Sell
381
-212
-36% -$1.65K ﹤0.01% 3344
2024
Q4 		$5.17K Buy
593
+61
+11% +$878 ﹤0.01% 2908
2024
Q3 		$10.4K Hold
532
– – ﹤0.01% 2441
2024
Q2 		$11K Sell
532
-19
-3% -$391 ﹤0.01% 2203
2024
Q1 		$11.8K Buy
551
+56
+11% +$1.09K ﹤0.01% 1973
2023
Q4 		$9.97K Buy
+495
New +$4.87K ﹤0.01% 1903

Other funds holding KURA

FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return

GAMMA Investing's KURA Position: Q3 2026 in Review

GAMMA Investing increased its Kura Oncology (KURA) stake by 16% in Q3 2026, buying an estimated $2.39K and bringing the position to 1,541 shares worth $16.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3059.

GAMMA Investing first reported a position in KURA in Q4 2023 and has held it in 12 quarters since. 5 funds tracked by Wall St. Rank hold KURA as of Q3 2026.

  • GAMMA Investing held 1,541 shares of Kura Oncology worth $16.5K as of Q3 2026.
  • GAMMA Investing bought 214 Kura Oncology shares in Q3 2026, an estimated $2.39K.
  • Kura Oncology made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #3059 holding.
  • GAMMA Investing first reported a position in Kura Oncology in Q4 2023 and has held it in 12 quarters since.
  • 5 funds tracked by Wall St. Rank held Kura Oncology as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.